A phase 2/3 randomized clinical trial followed by an open|label ...

Phases of Clinical Trials - MD Anderson Cancer Center

Learn about the four clinical trial phases of the MD Anderson treatment process that we utilize to ensure you receive the best care and treatment.

ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating ...

The open-label phase I ReCLAIM elamipretide study reported vision ... randomized pivotal phase 2/3 trial. Ophthalmology. 2021; 128:576-586. Full Text.

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ...

In this phase 3a, open-label, parallel-group, randomized controlled trial, 813 subjects with type 2 diabetes taking oral antidiabetic drugs were ...

Ide-cel or Standard Regimens in Relapsed and Refractory Multiple ...

In this international, randomized, open-label, phase 3 trial, we enrolled ... The KarMMa-3 trial was a phase 3, randomized, clinical trial for the ...

Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of ...

These findings suggest that treatment of CDI with ridinilazole results in an earlier recovery of gut microbiome health. Clinical Trials ...

Sequential [177Lu]Lu-PSMA-617 and docetaxel versus ... - The Lancet

UpFrontPSMA was an investigator-initiated, multicentre, open-label, randomised, phase 2 trial done at 11 Australian hospitals. Eligible ...

Merck Announces Phase 3 Trial Initiations for Four Investigational ...

MK-2870-004 is a Phase 3, global, randomized, open-label, active-comparator-controlled clinical study evaluating MK-2870 compared to ...

LBA8 A randomised phase III trial of induction chemotherapy ...

A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer.

Types of clinical trials | Cancer Research UK

As well as phase 1, 2 and 3 trials, other types of trials include pilot studies and feasibility studies as well as observational studies.

Sacituzumab Govitecan Versus Docetaxel for Previously Treated ...

... accompanied by significant treatment-related adverse events ... randomised, open-label, controlled, phase 3 trial. Lancet 393:1819 ...

UCSF Multiple Myeloma Clinical Trials — San Francisco Bay Area

This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR ...

Clinical trials in human medicines

Although clinical trials are authorised at national level in the European Union (EU), EMA plays a key role in further developing the EU as a competitive centre ...

Treatment Clinical Trials for Rectal Cancer - NCI

This is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulating tumor ...

A Phase II randomized controlled trial evaluated antithrombotic ...

... level. FXI, factor XI. The treatment period ended 28 days after the last administration of study drug and was followed by a 16-week follow-up period. Major ...

Clinical Trial A phase 2b, randomized, double-blind, placebo ...

... open-label treatment with atacicept 150 mg for an additional 60 weeks. Study assessments during this open-label extension period will be conducted at weeks ...

Shionogi Clinical Trials in the U.S.

is a Phase 1, randomized, double-blind, controlled, drug-drug ... ) is a Phase 1b/2, multicenter, open-label study of S-531011 as monotherapy ...

A randomized, double-blind, phase 2b proof-of-concept clinical trial ...

However, prespecified 18-month Bayesian and frequentist analyses demonstrated reduction in brain amyloid accompanied by a consistent reduction ...

Find a Clinical Trial - Lehigh Valley Health Network

Chronic HCV: AI452-032- Phase 3 open label study ... Chronic Hepatitis C and Chronic Kidney Disease/ A Phase II/III Randomized Clinical ... 2, 3, 4, 5, or 6).

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ...

A prospective, multicenter, open-label, randomized clinical trial comparing ABX-CBL to antithymocyte globulin (ATG) for treatment of steroid-resistant acute ...

A phase 2/3 randomized clinical trial followed by an open-label ...

A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of ...